# Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

> **NCT00235911** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 100 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** budesonide/formoterol Turbuhaler

## Key facts

- **NCT ID:** NCT00235911
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2006-10
- **Final completion:** 2006-12
- **Target enrollment:** 100 (—)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235911, "Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00235911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*